Back
Amicus Therapeutics, Inc. Stock Predictions
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
85
FOLD
Amicus Therapeutics, Inc.
Last Price:
$14.28
Seasonality Move:
1.06%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atAmicus Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Amicus Therapeutics, Inc. has on average historically risen by 20.2% based on the past 18 years of stock performance.
-
Amicus Therapeutics, Inc. has risen higher in 7 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.89%
-
Is Amicus Therapeutics, Inc. Stock Undervalued?The current Amicus Therapeutics, Inc. [FOLD] share price is $14.28. The Score for FOLD is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
-
FOLD is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
Will Amicus Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Amicus Therapeutics, Inc. has on average historically risen by 20.2% based on the past 18 years of stock performance.
Amicus Therapeutics, Inc. Stock Rating
Buy
85
Amicus Therapeutics, Inc. (FOLD)
is a Buy
Is Amicus Therapeutics, Inc. overpriced?
-
Amicus Therapeutics, Inc. has risen higher in 7 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.89%
Amicus Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com
52-Week Data
52-Week High:
14.36
52-Week Low:
5.51
Prediction Charts
Market Cap:
4.4B
Price in USD:
14.28
Volume:
10.5M
Beta:
0.97
Technical Analysis
SMA50:
10.85
SMA100:
9.45
SMA200:
7.99
52-Wk Change:
50.95%
Stock Predictions
-
Is Amicus Therapeutics, Inc. stock public?Yes, Amicus Therapeutics, Inc. is a publicly traded company.
-
What is the Amicus Therapeutics, Inc. stock quote today?The Amicus Therapeutics, Inc. stock price is 14.28 USD today.
-
How to buy Amicus Therapeutics, Inc. stock online?You can buy Amicus Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-18 | 10.96 | 10.89 | 11.00 | 10.64 |
| Dec-19 | 14.18 | 14.18 | 14.36 | 14.16 |
| Dec-22 | 14.19 | 14.21 | 14.26 | 14.18 |
| Dec-23 | 14.22 | 14.21 | 14.22 | 14.18 |
| Dec-24 | 14.21 | 14.25 | 14.26 | 14.21 |
| Dec-26 | 14.23 | 14.25 | 14.28 | 14.23 |
| Dec-29 | 14.24 | 14.25 | 14.28 | 14.23 |
| Dec-30 | 14.26 | 14.25 | 14.26 | 14.23 |
| Dec-31 | 14.25 | 14.24 | 14.27 | 14.23 |
| Jan-5 | 14.25 | 14.25 | 14.26 | 14.21 |
| Jan-6 | 14.25 | 14.28 | 14.29 | 14.24 |
| Jan-7 | 14.29 | 14.30 | 14.35 | 14.27 |
| Jan-8 | 14.32 | 14.28 | 14.32 | 14.26 |
| Jan-9 | 14.28 | 14.28 | 14.30 | 14.28 |
Amicus Therapeutics, Inc. Earnings
Amicus Therapeutics, Inc. Earnings Report: Per Share Amicus Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Amicus Therapeutics, Inc. Forecast Revenue Growth
Amicus Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.28 per share.
* Amicus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.